Malaria Vaccine Debate
Full Debate: Read Full DebateLord Hunt of Kings Heath
Main Page: Lord Hunt of Kings Heath (Labour - Life peer)Department Debates - View all Lord Hunt of Kings Heath's debates with the Foreign, Commonwealth & Development Office
(4 years ago)
Lords ChamberMy Lords, I assure the noble Lord that I agree with him on the important work being done to fight malaria. I have been involved in some of the direct campaigns, and we have seen some real benefits. In relation to the ODA reduction, as I said during the repeat of the Statement in your Lordships’ House, there will of course be reductions across the budgets. We are currently working through that exercise, and my right honourable friend the Foreign Secretary is overseeing that programme directly. At this point, as I have said previously in your Lordships’ House, I cannot give the specific commitment that the noble Lord desires, but we hope to have more details of our planned priorities and spend, including important projects that we will be protecting, in the new year.
My Lords, this is very good news. My question to the Minister is on the cost of a vaccine. The Government have signed up to COVAX to allow for the procurement of vaccines at a negotiated price from vaccine manufacturers on behalf of low and middle-income countries. Will this apply to the malaria vaccine we have been discussing, and will costs to the countries involved—mainly in sub-Saharan Africa—be kept as low as possible?
My Lords, I agree with the noble Lord—the leadership that the United Kingdom has shown on equitable access in relation to the Covid-19 vaccine certainly underlines our commitment to ensuring that the most vulnerable receive the vaccines required. On the malaria vaccine, we are working closely through multilateral organisations that fund the continued research into and testing of those vaccines. I agree with the noble Lord that, as these vaccines come online, it is important that they are game-changers on the ground, particularly in the most vulnerable parts of the world. We should ensure the lowest cost for and equitable access to those vaccines.